Hutson Nancy J

Director at INSPIRE PHARMACEUTICALS INC · on record since Oct 30, 2006
Director at CUBIST PHARMACEUTICALS INC · on record since Jun 16, 2008
Director at ENDO HEALTH SOLUTIONS INC. · on record since Mar 31, 2009
Director at BIOCRYST PHARMACEUTICALS INC · on record since Jan 23, 2012
Director at PhaseBio Pharmaceuticals Inc · on record since Oct 17, 2018
Director at Clearside Biomedical, Inc. · on record since Apr 23, 2020

Insider trading activity of Hutson Nancy J

Transactions on record: 185; since Oct 30, 2006

Open-market buys: 19; $537K

Open-market sells: 13; $4.4M

Companies traded: 7; last filing Jun 16, 2025

Figures computed from official regulatory filings — .

Companies where Hutson Nancy J has traded

BIOCRYST PHARMACEUTICALS INC58 tx · $2.9M · Jun 16, 2025
Clearside Biomedical, Inc.15 tx · $171.7K · Jun 21, 2024
PhaseBio Pharmaceuticals Inc16 tx · $182.1K · May 19, 2023
Endo International plc19 tx · $1.3M · Jun 15, 2021
CUBIST PHARMACEUTICALS INC40 tx · $2.6M · Jan 21, 2015
ENDO HEALTH SOLUTIONS INC.19 tx · $85.3K · Mar 3, 2014
INSPIRE PHARMACEUTICALS INC18 tx · $172.4K · May 16, 2011

Track record of Hutson Nancy J

Statistical track record

Free account

Open-market buys: 19

Last buy: May 20, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Hutson Nancy J

Co-insiders of Hutson Nancy J

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 16, 2025	Award	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 16, 2025	AwardD (derivative)	27,181	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 16, 2024	Sell	-7,000	7.54 USD	$52.8K		SEC
Clearside Biomedical, Inc.Listing unverified	Jun 21, 2024	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 14, 2024	AwardD (derivative)	49,933	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 14, 2024	Award	6,820	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	May 22, 2024	Buy	5,000	6.38 USD	$31.9K	conv 40Cluster	SEC
Clearside Biomedical, Inc.Listing unverified	Oct 4, 2023	Buy	10,000	0.86 USD	$8.6K	conv 31	SEC
Clearside Biomedical, Inc.Listing unverified	Jun 23, 2023	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 15, 2023	Sell	-12,866	8.04 USD	$103.4K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 15, 2023	AwardD (derivative)	39,072	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 15, 2023	Award	16,745	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PhaseBio Pharmaceuticals IncListing unverified	May 19, 2023	Exercise	3,750	—	n/a (No price was disclosed in the filing)		SEC
PhaseBio Pharmaceuticals IncListing unverified	May 19, 2023	ExerciseD (derivative)	-3,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Clearside Biomedical, Inc.Listing unverified	Nov 21, 2022	Buy	30,000	1.33 USD	$39.9K	conv 50First in 12mo	SEC
Clearside Biomedical, Inc.Listing unverified	Jun 24, 2022	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 9, 2022	Award	12,866	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 9, 2022	AwardD (derivative)	30,022	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PhaseBio Pharmaceuticals IncListing unverified	May 20, 2022	AwardD (derivative)	3,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PhaseBio Pharmaceuticals IncListing unverified	May 20, 2022	Buy	3,000	3.08 USD	$9.2K	conv 42	SEC
PhaseBio Pharmaceuticals IncListing unverified	May 20, 2022	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PhaseBio Pharmaceuticals IncListing unverified	Nov 8, 2021	ExerciseD (derivative)	-1,500	3.15 USD	$4.7K		SEC
PhaseBio Pharmaceuticals IncListing unverified	Nov 8, 2021	Exercise	7,400	3.15 USD	$23.3K		SEC
PhaseBio Pharmaceuticals IncListing unverified	Nov 8, 2021	ExerciseD (derivative)	-7,400	3.15 USD	$23.3K		SEC
PhaseBio Pharmaceuticals IncListing unverified	Nov 8, 2021	Exercise	24,860	2.26 USD	$56.2K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 16, 2025	Award	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 16, 2025	AwardD (derivative)	27,181	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Dec 16, 2024	Sell	-7,000	7.54 USD	$52.8K		SEC
Clearside Biomedical, Inc.Listing unverified	Jun 21, 2024	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 14, 2024	AwardD (derivative)	49,933	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 14, 2024	Award	6,820	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	May 22, 2024	Buy	5,000	6.38 USD	$31.9K	conv 40Cluster	SEC
Clearside Biomedical, Inc.Listing unverified	Oct 4, 2023	Buy	10,000	0.86 USD	$8.6K	conv 31	SEC
Clearside Biomedical, Inc.Listing unverified	Jun 23, 2023	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 15, 2023	Sell	-12,866	8.04 USD	$103.4K		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 15, 2023	AwardD (derivative)	39,072	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 15, 2023	Award	16,745	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PhaseBio Pharmaceuticals IncListing unverified	May 19, 2023	Exercise	3,750	—	n/a (No price was disclosed in the filing)		SEC
PhaseBio Pharmaceuticals IncListing unverified	May 19, 2023	ExerciseD (derivative)	-3,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Clearside Biomedical, Inc.Listing unverified	Nov 21, 2022	Buy	30,000	1.33 USD	$39.9K	conv 50First in 12mo	SEC
Clearside Biomedical, Inc.Listing unverified	Jun 24, 2022	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 9, 2022	Award	12,866	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOCRYST PHARMACEUTICALS INCListing on record	Jun 9, 2022	AwardD (derivative)	30,022	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PhaseBio Pharmaceuticals IncListing unverified	May 20, 2022	AwardD (derivative)	3,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PhaseBio Pharmaceuticals IncListing unverified	May 20, 2022	Buy	3,000	3.08 USD	$9.2K	conv 42	SEC
PhaseBio Pharmaceuticals IncListing unverified	May 20, 2022	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PhaseBio Pharmaceuticals IncListing unverified	Nov 8, 2021	ExerciseD (derivative)	-1,500	3.15 USD	$4.7K		SEC
PhaseBio Pharmaceuticals IncListing unverified	Nov 8, 2021	Exercise	7,400	3.15 USD	$23.3K		SEC
PhaseBio Pharmaceuticals IncListing unverified	Nov 8, 2021	ExerciseD (derivative)	-7,400	3.15 USD	$23.3K		SEC
PhaseBio Pharmaceuticals IncListing unverified	Nov 8, 2021	Exercise	24,860	2.26 USD	$56.2K		SEC